KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Asset Utilization Ratio (2021 - 2024)

AbCellera Biologics (ABCL) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.01 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Asset Utilization Ratio fell 80.2% year-over-year to 0.01, compared with a TTM value of 0.01 through Sep 2024, down 80.2%, and an annual FY2024 reading of 0.02, down 19.37% over the prior year.
  • Asset Utilization Ratio was 0.01 for Q3 2024 at AbCellera Biologics, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.4 in Q1 2021 and bottomed at 0.01 in Q3 2024.
  • Average Asset Utilization Ratio over 4 years is 0.21, with a median of 0.3 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio grew 4.19% in 2022, then tumbled 91.92% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.3 in 2021, then increased by 4.19% to 0.31 in 2022, then crashed by 91.92% to 0.03 in 2023, then plummeted by 74.18% to 0.01 in 2024.
  • Business Quant data shows Asset Utilization Ratio for ABCL at 0.01 in Q3 2024, 0.01 in Q2 2024, and 0.02 in Q1 2024.